Notice of Information for RFA-HD-21-005, Genomic Predictors of Pregnancy Loss (R01 Clinical Trial Not Allowed)
Notice Number:
NOT-HD-20-015

Key Dates

Release Date:
May 13, 2020

Related Announcements

Issued by

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Purpose

The purpose of this Notice is to inform applicants of the expansion of the research scope for RFA-HD-21-005 “Genomic Predictors of Pregnancy Loss”.

Part 2. Full Text of Announcement

Section I. Funding Opportunity Description

Research Scope

The FOA currently reads:

The scope of this FOA is restricted to the study of couples who have experienced unexplained pregnancy loss due to: 1) fetal anomalies not associated with known aneuploidy, and/or 2) recurrent pregnancy loss (defined as 2 or more pregnancy losses) not related to well-defined causes of pregnancy loss such as fetal aneuploidy, parental chromosome translocation, immunologic or thrombophilic disorders, or uterine anomalies. The recruitment of diverse populations is strongly encouraged.

This section of the FOA is modified to read:

The scope of this FOA is restricted to the study of couples who have experienced: 1) pregnancy loss at >20 weeks with or without fetal anomalies, and/or 2) recurrent pregnancy loss (defined as 2 or more pregnancy losses). The losses should not be related to well-defined causes of pregnancy loss or preterm delivery such as fetal aneuploidy, parental chromosome translocation, immunologic or thrombophilic disorders, uterine anomalies, abruption, pre-eclampsia, infection, etc.

All other aspects of RFA-HD-21-005 remain unchanged.

Inquiries

Please direct all inquiries to:

Lisa M. Halvorson, MD
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-480-1646
Email: [email protected]


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices